Hearing that your child has neuroblastoma can be frightening and overwhelming. It can be daunting to think about the treatments your child may need and how the experience will affect your child, your ...

Today, December 5th, marks the first-ever International Neuroblastoma Awareness Day—a Global Day of Action and unity to fight for children battling this devastating disease. Neuroblastoma is a ...

Neuroblastoma is the most common extracranial solid tumor in children, with nearly 50% of cases diagnosed at an advanced stage, often with metastatic disease. Despite advances in treatment, survival ...

To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...

Essential Pharma has bought fellow UK drugmaker Renaissance Pharma, adding its first development-stage drug candidate, a therapy for hard-to-treat rare cancer neuroblastoma. The takeover of ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

NICE has said EUSA Pharma’s Qarziba for the rare childhood cancer high-risk neuroblastoma should not get regular funding from the NHS – but could be given interim funding on the Cancer Drugs ...

Antonya Cooper’s son Hamish had been suffering from stage 4 neuroblastoma – a rare childhood cancer – when he died at home aged seven on December 1 1981. Ms Cooper, a former chairwoman of ...

Two-year-old Hunter Parker was diagnosed with Neuroblastoma at just 16 weeks old before going on to spend over 100 days in ...

Evaluating Paediatric Oncology Operative Reports as an Impetus for Synoptic Reports,” published in the February 2025 issue of Pediatrics by Petrushkevich et al. This study aims to audit pediatric ...